The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Wright Medical Group Inc

Nasdaq: WMGI
Last

(U.S.) $23.28

Today's change-0.15 -0.64%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Wright Medical Group Inc

Nasdaq: WMGI
Last

(U.S.) $23.28

Today's change-0.15 -0.64%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Wright Medical Group Inc down (U.S.)$0.15

Wright Medical Group Inc closed lower Friday, dropping (U.S.)$0.15 or 0.64% to (U.S.)$23.28. Over the last five days, shares have gained 1.00%, but are down 13.36% for the last year to date. Shares have underperformed the S&P 500 by 21.14% during the last year.

Key company metrics

  • Open(U.S.) $23.36
  • Previous close(U.S.) $23.43
  • High(U.S.) $23.55
  • Low(U.S.) $23.18
  • Bid / Ask-- / --
  • YTD % change-13.36%
  • Volume314,635
  • Average volume (10-day)435,955
  • Average volume (1-month)483,476
  • Average volume (3-month)540,851
  • 52-week range(U.S.) $22.17 to (U.S.) $32.65
  • Beta0.49
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$4.74
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-76.74%

Wright Medical Group Inc has a net profit margin of -76.74%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue80788371
Total other revenue--------
Total revenue80788371
Gross profit59596455
Total cost of revenue22191917
Total operating expense11511111092
Selling / general / administrative71716663
Research & development8766
Depreciation / amortization3332
Interest expense (income), net operating--------
Unusual expense (income)1211164
Other operating expenses, total--------
Operating income-34-33-27-21
Interest income (expense), net non-operating-11-8-5-5
Gain (loss) on sale of assets--------
Other--------
Income before tax-37-46-106-47
Income after tax-37-46-107-50
Income tax, total0013
Net income-44-50-111-62
Total adjustments to net income--------
Net income before extra. items-37-46-107-50
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-37-46-107-50
Inc. avail. to common incl. extra. items-44-50-111-62
Diluted net income-44-50-111-62
Dilution adjustment--000
Diluted weighted average shares51515150
Diluted EPS excluding extraordinary itemsvalue per share-0.73-0.91-2.11-0.99
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.58-0.77-1.91-0.93